ALB - Albemarle Corp Stock Price, Fair Value and News

130.51USD-1.04 (-0.79%)Market Closed

Market Summary

USD130.51-1.04

Market Closed

-0.79%

ALB Alerts

Big fall in Revenue (Y/Y)

Big fall in earnings (Y/Y)

ALB Stock Price

View Fullscreen

ALB RSI Chart

ALB Valuation

Market Cap

15.3B

Price/Earnings (Trailing)

45.47

Price/Sales (Trailing)

1.83

EV/EBITDA

-27.46

Price/Free Cashflow

-9.52

ALB Price/Sales (Trailing)

ALB Profitability

Operating Margin

-0.62%

EBT Margin

-12.84%

Return on Equity

2.86%

Return on Assets

1.77%

Free Cashflow Yield

-10.5%

ALB Fundamentals

ALB Revenue

Revenue (TTM)

8.4B

Rev. Growth (Yr)

-47.26%

Rev. Growth (Qtr)

-42.25%

ALB Earnings

Earnings (TTM)

337.3M

Earnings Growth (Yr)

-99.8%

Earnings Growth (Qtr)

100.4%

Breaking Down ALB Revenue

Last 7 days

9.7%

Last 30 days

-0.9%

Last 90 days

14.2%

Trailing 12 Months

-33.1%

How does ALB drawdown profile look like?

ALB Financial Health

Current Ratio

2.84

Debt/Equity

0.3

Debt/Cashflow

0.2

ALB Investor Care

Dividend Yield

1.23%

Dividend/Share (TTM)

1.6

Shares Dilution (1Y)

0.16%

Diluted EPS (TTM)

2.77

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	8.4B	0	0	0
2023	8.8B	9.7B	9.9B	9.6B
2022	3.6B	4.3B	5.6B	7.3B
2021	3.2B	3.2B	3.3B	3.3B
2020	3.5B	3.4B	3.2B	3.1B
2019	3.4B	3.4B	3.5B	3.6B
2018	3.2B	3.3B	3.3B	3.4B
2017	2.7B	2.8B	2.9B	3.1B
2016	2.8B	2.7B	2.7B	2.7B
2015	2.5B	2.7B	2.7B	2.8B
2014	2.4B	2.4B	2.5B	2.4B
2013	2.4B	2.4B	2.4B	2.4B
2012	2.8B	2.7B	2.6B	2.5B
2011	2.5B	2.6B	2.8B	2.9B
2010	2.1B	2.2B	2.3B	2.4B
2009	0	2.3B	2.2B	2.0B
2008	0	0	0	2.5B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Albemarle Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 28, 2024	norris eric	sold (taxes)	-98,120	132	-743	president, energy storage
Feb 28, 2024	norris eric	acquired	-	-	1,680	president, energy storage
Feb 28, 2024	fourie jacobus g.	acquired	-	-	917	chief capital projects officer
Feb 28, 2024	johnson netha n.	sold (taxes)	-98,120	132	-743	president, specialties
Feb 28, 2024	fourie jacobus g.	sold (taxes)	-53,616	132	-406	chief capital projects officer
Feb 28, 2024	barichivich john clarence iii	acquired	-	-	535	vp, controller & cao
Feb 28, 2024	johnson netha n.	acquired	-	-	1,680	president, specialties
Feb 28, 2024	barichivich john clarence iii	sold (taxes)	-20,733	132	-157	vp, controller & cao
Feb 26, 2024	norris eric	sold (taxes)	-154,087	121	-1,268	president, energy storage
Feb 26, 2024	lima cynthia renee	acquired	-	-	753	svp, ext. affairs & comm.

Which funds bought or sold ALB recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 07, 2024	Arizona State Retirement System	added	0.08	-407,465	4,252,300	0.03%
May 07, 2024	OPPENHEIMER & CO INC	added	6.23	-118,580	3,656,970	0.06%
May 07, 2024	KCM INVESTMENT ADVISORS LLC	added	32.29	249,179	1,457,180	0.05%
May 07, 2024	Pointe Capital Management LLC	unchanged	-	-29,225	302,212	0.18%
May 07, 2024	Atomi Financial Group, Inc.	new	-	275,485	275,485	0.03%
May 07, 2024	SEI INVESTMENTS CO	added	4.72	-2,702,620	57,205,600	0.08%
May 07, 2024	Concurrent Investment Advisors, LLC	added	55.64	121,765	412,294	0.02%
May 07, 2024	WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC	unchanged	-	-52,018	537,894	0.01%
May 07, 2024	PANAGORA ASSET MANAGEMENT INC	unchanged	-	-86,097	890,299	-%
May 07, 2024	Swiss National Bank	reduced	-4.22	-6,716,350	46,294,200	0.03%

Are Funds Buying or Selling ALB?

Are funds buying ALB calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own ALB

No. of Funds

Unveiling Albemarle Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.00%	14,083,522	SC 13G/A
Feb 09, 2024	capital international investors	5.1%	5,942,956	SC 13G/A
Feb 09, 2024	capital research global investors	6.0%	7,076,357	SC 13G
Jan 25, 2024	blackrock inc.	8.7%	10,187,246	SC 13G/A
Feb 13, 2023	capital international investors	6.7%	7,868,987	SC 13G
Feb 09, 2023	vanguard group inc	12.10%	14,174,413	SC 13G/A
Feb 03, 2023	blackrock inc.	8.0%	9,321,844	SC 13G/A
Feb 09, 2022	vanguard group inc	11.61%	13,585,134	SC 13G/A
Feb 09, 2022	state street corp	4.57%	5,348,397	SC 13G/A
Feb 03, 2022	franklin resources inc	4.2%	4,910,125	SC 13G/A

Recent SEC filings of Albemarle Corp

View All Filings

Date Filed	Form Type	Document
May 01, 2024	10-Q	Quarterly Report
May 01, 2024	8-K	Current Report
Mar 28, 2024	10-K/A	Annual Report
Mar 26, 2024	DEF 14A	DEF 14A
Mar 26, 2024	DEFA14A	DEFA14A
Mar 12, 2024	PRE 14A	PRE 14A
Mar 08, 2024	8-A12B	8-A12B
Mar 08, 2024	8-K	Current Report
Mar 08, 2024	CERT	CERT
Mar 07, 2024	424B2	Prospectus Filed

Peers (Alternatives to Albemarle Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
APD	54.8B	12.2B	3.67%	-12.00%	22.19	4.51	-7.47%	13.44%
DOW	41.3B	43.5B	-1.50%	9.24%	32.55	0.95	-18.61%	-57.39%
CE	17.8B	10.9B	-0.86%	56.21%	9.07	1.63	13.10%	3.48%
AVTR	16.5B	6.9B	-5.45%	19.15%	63.41	2.4	-6.48%	-57.90%
ALB	15.3B	8.4B	-0.90%	-33.13%	45.47	1.83	-4.27%	-90.82%
EMN	11.9B	9.1B	0.21%	25.72%	12.81	1.3	-11.38%	33.67%
MID-CAP
CBT	5.6B	3.9B	7.28%	48.47%	12.61	1.43	-9.12%	26.64%
BCPC	5.0B	929.6M	0.20%	21.97%	43.23	5.34	-1.74%	15.81%
AVNT	4.1B	3.1B	5.69%	18.08%	39.2	1.32	-6.69%	-83.56%
ARCH	2.9B	3.0B	4.03%	24.60%	9.03	0.98	-20.68%	-74.38%
SMALL-CAP
CCF	1.2B	404.0M	0.11%	32.60%	36.59	3	24.06%	-25.72%
ASIX	646.9M	1.5B	-13.83%	-28.91%	284.59	0.44	-21.27%	-97.94%
CMT	179.5M	336.4M	10.78%	-1.75%	9.85	0.53	-12.92%	28.47%
AREC	99.8M	16.7M	-8.03%	-13.70%	-8.43	5.96	-57.58%	-718.66%
AMRS	3.7M	-	-80.00%	-99.58%	-0.01	0.01	-	-

Albemarle Corp News

Latest updates

Albemarle Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-42.2%	1,361	2,356	2,311	2,370	2,580	2,621	2,092	1,480	1,128	894	831	774	829	879	747	764	739	993	880	885	832
Cost Of Revenue	-56.8%	1,322	3,060	2,256	1,812	1,304	1,620	1,048	899	679	658	581	525	566	614	493	531	497	654	570	559	549
Gross Profit	105.5%	39.00	-704	55.00	558	1,277	1,001	1,044	580	449	237	249	248	264	265	254	233	242	339	310	326	283
S&GA Expenses	0.3%	195	194	174	397	154	148	134	129	113	123	103	122	93.00	125	96.00	107	102	185	108	127	113
R&D Expenses	3.4%	24.00	23.00	21.00	21.00	20.00	20.00	18.00	17.00	16.00	12.00	13.00	14.00	15.00	15.00	14.00	14.00	16.00	14.00	16.00	13.00	15.00
EBITDA Margin	-203.6%	-0.07*	0.07*	0.25*	0.36*	0.42*	0.38*	0.34*	0.11*	0.17*	0.13*	0.14*	0.34*	-	-	-	-	-	-	-	-	-
Income Taxes	-103.1%	-3.72	119	-8.55	43.00	277	24.00	197	89.00	81.00	15.00	-114	107	22.00	-10.10	31.00	15.00	18.00	-5.11	25.00	30.00	38.00
Earnings Before Taxes	81.8%	-167	-920	-158	168	1,157	863	869	401	300	-8.06	-516	535	123	48.00	122	88.00	115	78.00	164	167	154
EBT Margin	-600.5%	-0.13*	0.03*	0.21*	0.32*	0.38*	0.33*	0.28*	0.04*	0.09*	0.04*	0.06*	0.26*	-	-	-	-	-	-	-	-	-
Net Income	100.4%	2.00	-617	303	650	1,239	1,132	897	407	253	-3.82	-392	425	96.00	85.00	98.00	86.00	107	90.00	155	154	134
Net Income Margin	-75.4%	0.04*	0.16*	0.34*	0.41*	0.42*	0.37*	0.28*	0.06*	0.08*	0.04*	0.06*	0.22*	-	-	-	-	-	-	-	-	-
Free Cashflow	38.5%	-481	-782	83.00	-429	305	507	582	-416	-25.52	-447	-151	11.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	4.2%	19,032	18,271	18,883	19,110	17,564	15,457	13,829	12,520	11,416	10,974	10,832	10,797	10,290	10,451	10,232	10,170	9,848	9,861	8,142	8,094	7,871
Current Assets	11.6%	5,823	5,217	7,126	7,455	6,658	5,187	4,297	3,350	2,336	1,994	2,078	2,151	2,009	2,206	2,227	2,292	2,155	2,225	1,970	2,037	1,987
Cash Equivalents	131.0%	2,056	890	1,602	1,600	1,587	1,499	1,383	931	463	439	595	824	570	747	702	737	553	613	318	398	465
Inventory	-11.9%	1,905	2,161	3,404	3,659	3,181	2,076	1,614	1,216	1,014	799	746	733	686	750	828	851	854	769	802	814	756
Net PPE	2.7%	9,756	9,495	8,309	7,855	7,353	6,963	6,425	6,208	6,029	5,910	5,655	5,511	5,390	5,355	5,243	5,136	5,026	4,909	3,524	3,391	3,170
Goodwill	-1.0%	1,614	1,630	1,606	1,635	1,634	1,618	1,468	1,543	1,576	1,598	1,623	1,641	1,629	1,666	1,603	1,571	1,559	1,579	1,534	1,566	1,561
Current Liabilities	-42.4%	2,051	3,560	3,942	4,292	3,505	2,741	2,488	1,782	2,103	1,874	1,591	985	953	1,802	1,613	1,421	1,193	1,409	1,421	1,400	1,278
Long Term Debt	-0.6%	3,519	3,541	3,496	3,509	3,233	3,215	3,119	3,206	1,986	2,004	2,021	2,044	2,030	2,767	2,941	3,132	3,105	2,863	1,382	1,398	1,394
LT Debt, Current	-99.2%	5.00	626	162	6.00	2.00	2.00	251	251	504	390	1.00	1.00	1.00	805	604	406	36.00	187	540	491	426
LT Debt, Non Current	-100.0%	-	3,541	3,496	3,509	3,233	3,215	3,119	3,206	1,986	2,004	2,021	2,044	2,030	2,767	2,941	3,132	3,105	2,863	1,382	1,398	1,394
Shareholder's Equity	25.4%	11,800	9,412	9,898	10,088	9,459	7,983	6,965	6,301	6,035	5,806	5,895	6,366	5,943	4,469	4,325	4,206	4,042	4,094	4,008	3,974	3,864
Retained Earnings	-0.8%	6,931	6,987	7,652	7,396	6,793	5,601	4,515	3,664	3,304	3,097	3,146	3,584	3,205	3,155	3,112	3,054	3,010	2,943	2,892	2,776	2,661
Additional Paid-In Capital	0.3%	2,963	2,953	2,946	2,936	2,932	2,941	2,934	2,927	2,915	2,920	2,913	2,908	2,890	1,438	1,411	1,400	1,394	1,383	1,379	1,373	1,368
Accumulated Depreciation	3.4%	2,832	2,739	2,621	2,542	2,477	2,391	2,289	2,257	2,210	2,165	2,128	2,086	2,043	2,073	2,042	2,003	1,948	1,908	1,882	1,858	1,813
Shares Outstanding	0.1%	118	117	117	117	117	117	117	117	117	116	117	117	-	-	-	-	-	-	-	-	-
Minority Interest	5.5%	267	253	265	273	246	208	232	216	208	180	201	200	196	200	201	182	164	161	172	174	192
Float	-	-	-	-	26,200	-	-	-	24,500	-	-	-	19,700	-	-	-	8,200	-	-	-	7,500	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	199.7%	98.00	-98.22	629	74.00	721	952	895	-145	206	-146	105	228	158	337	254	53.00	155	374	146	144	55.00
Share Based Compensation	31.6%	9.00	7.00	9.00	9.00	11.00	6.00	9.00	11.00	4.00	5.00	6.00	6.00	3.00	7.00	6.00	7.00	3.00	5.00	5.00	5.00	6.00
Cashflow From Investing	53.6%	-494	-1,065	-662	-513	-539	-609	-313	-271	-228	-307	-256	73.00	-174	-220	-202	-205	-234	-1,064	-192	-199	-207
Cashflow From Financing	292.3%	1,557	397	100	246	-118	-299	-65.28	919	58.00	309	-63.90	-51.28	-143	-101	-95.85	324	51.00	987	-6.72	-13.29	75.00
Dividend Payments	-100.0%	-	47.00	47.00	47.00	46.00	46.00	46.00	46.00	46.00	46.00	46.00	46.00	41.00	41.00	41.00	41.00	39.00	39.00	39.00	39.00	35.00
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

ALB Income Statement

2024-03-31

Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Income Statement [Abstract]

Net sales

$ 1,360,736

$ 2,580,252

Cost of goods sold

^[1]

1,321,798

1,303,712

Gross profit

38,938

1,276,540

Selling, general and administrative expenses

194,912

154,306

Research and development expenses

23,532

20,471

Operating (loss) profit

(179,506)

1,101,763

Interest and financing expenses

(37,969)

(26,777)

Other income, net

49,901

82,492

(Loss) income before income taxes and equity in net income of unconsolidated investments

(167,574)

1,157,478

Income tax (benefit) expense

(3,721)

276,963

(Loss) income before equity in net income of unconsolidated investments

(163,853)

880,515

Equity in net income of unconsolidated investments (net of tax)

180,500

396,188

Net income

16,647

1,276,703

Net income attributable to noncontrolling interests

(14,199)

(38,123)

Net income attributable to Albemarle Corporation

2,448

1,238,580

Mandatory convertible preferred stock dividends

(11,584)

Net (loss) income attributable to Albemarle Corporation common shareholders

$ (9,136)

$ 1,238,580

Basic (loss) earnings per share attributable to common shareholders (in dollars per share)

$ (0.08)

$ 10.57

Diluted (loss) earnings per share attributable to common shareholders (in dollars per share)

$ (0.08)

$ 10.51

Weighted-average common shares outstanding - basic (in shares)

117,451

117,232

Weighted-average common shares outstanding - diluted (in shares)

117,451

117,841

[1]	Included purchases from related unconsolidated affiliates of $540.7 million and $353.2 million for the three-month periods ended March 31, 2024 and 2023, respectively.

ALB Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 2,055,813	$ 889,900
Trade accounts receivable, less allowance for doubtful accounts (2024 – $2,761; 2023 – $2,808)	874,038	1,213,160
Other accounts receivable	438,507	509,097
Inventories	1,904,827	2,161,287
Other current assets	549,540	443,475
Total current assets	5,822,725	5,216,919
Property, plant and equipment, at cost	12,587,763	12,233,757
Less accumulated depreciation and amortization	2,831,728	2,738,553
Net property, plant and equipment	9,756,035	9,495,204
Investments	1,259,001	1,369,855
Other assets	329,283	297,087
Goodwill	1,613,534	1,629,729
Other intangibles, net of amortization	251,755	261,858
Total assets	19,032,333	18,270,652
Current liabilities:
Accrued expenses	454,600	544,835
Current portion of long-term debt	5,076	625,761
Dividends payable	58,354	46,666
Income taxes payable	237,098	255,155
Total current liabilities	2,050,696	3,560,462
Long-term debt	3,519,453	3,541,002
Postretirement benefits	26,382	26,247
Pension benefits	145,067	150,312
Other noncurrent liabilities	833,548	769,100
Deferred income taxes	657,468	558,430
Commitments and contingencies (Note 6)
Albemarle Corporation shareholders’ equity:
Common stock, $.01 par value, authorized – $150,000 issued and outstanding – 117,527 in 2024 and 117,356 in 2023	1,175	1,174
Mandatory convertible preferred stock, Series A, no par value, $1,000 stated value, authorized – 15,000, issued and outstanding – 2,300 in 2024 and 0 in 2023	2,235,379	0
Additional paid-in capital	2,962,585	2,952,517
Accumulated other comprehensive loss	(597,205)	(528,526)
Retained earnings	6,930,868	6,987,015
Total Albemarle Corporation shareholders’ equity	11,532,802	9,412,180
Noncontrolling interests	266,917	252,919
Total equity	11,799,719	9,665,099
Total liabilities and equity	19,032,333	18,270,652
Nonrelated Party
Current liabilities:
Accounts payable	1,165,955	1,537,859
Related Party
Current liabilities:
Accounts payable	$ 129,613	$ 550,186

About Albemarle Corp

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

CEO	Mr. Jerry Kent Masters Jr.
WEBSITE	albemarle.com
INDUSTRY	Chemicals
EMPLOYEES	7400

Albemarle Corp Frequently Asked Questions

What is the ticker symbol for Albemarle Corp? What does ALB stand for in stocks?

ALB is the stock ticker symbol of Albemarle Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Albemarle Corp (ALB)?

As of Wed May 08 2024, market cap of Albemarle Corp is 15.34 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ALB stock?

You can check ALB's fair value in chart for subscribers.

What is the fair value of ALB stock?

You can check ALB's fair value in chart for subscribers. The fair value of Albemarle Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Albemarle Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ALB so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Albemarle Corp a good stock to buy?

The fair value guage provides a quick view whether ALB is over valued or under valued. Whether Albemarle Corp is cheap or expensive depends on the assumptions which impact Albemarle Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ALB.

What is Albemarle Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed May 08 2024, ALB's PE ratio (Price to Earnings) is 45.47 and Price to Sales (PS) ratio is 1.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ALB PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Albemarle Corp's stock?

In the past 10 years, Albemarle Corp has provided 0.081 (multiply by 100 for percentage) rate of return.